SPX5,675.29+60.63 1.08%
DIA420.42+3.89 0.93%
IXIC17,750.79+246.67 1.41%

This UiPath Analyst Turns Bearish; Here Are Top 5 Downgrades For Thursday

Benzinga·03/13/2025 12:55:57
Listen to the news

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • B of A Securities analyst Brad Sills downgraded the rating for UiPath Inc. (NYSE:PATH) from Neutral to Underperform and lowered the price target from $18 to $10. UiPath shares closed at $11.83 on Wednesday. See how other analysts view this stock.
  • Morgan Stanley analyst Ryan Kenny downgraded Moelis & Company (NYSE:MC) from Overweight to Underweight and lowered the price target from $100 to $70. Moelis shares closed at $60.09 on Wednesday. See how other analysts view this stock.
  • Needham analyst David Saxon downgraded the rating for DENTSPLY SIRONA Inc. (NASDAQ:XRAY) from Buy to Hold. Dentsply Sirona shares closed at $15.33 on Wednesday. See how other analysts view this stock.
  • Truist Securities analyst Ki Bin Kim downgraded Federal Realty Investment Trust (NYSE:FRT) from Buy to Hold and lowered the price target from $114 to $105. Federal Realty Investment shares closed at $97.12 on Wednesday. See how other analysts view this stock.
  • Needham analyst David Saxon downgraded the rating for ZimVie Inc. (NASDAQ:ZIMV) from Buy to Hold. ZimVie shares closed at $12.65 on Wednesday. See how other analysts view this stock.

Considering buying PATH stock? Here’s what analysts think:

Read This Next: